Enlitic, Inc. (ASX:ENL)
Australia
· Delayed Price · Currency is AUD 0.0500
0.00 (0.00%)
At close: Apr 28, 2025, 4:00 PM AEST
Enlitic Revenue
In the year 2024, Enlitic had annual revenue of $1.20M USD with 115.54% growth. Enlitic had revenue of $997.68K in the half year ending December 31, 2024, with 122.09% growth.
Revenue
$1.20M
Revenue Growth
+115.54%
P/S Ratio
15.01
Revenue / Employee
n/a
Employees
n/a
Market Cap
29.16M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.20M | 644.33K | 115.54% |
| Dec 31, 2023 | 557.68K | -345.60K | -38.26% |
| Dec 31, 2022 | 903.28K | -390.69K | -30.19% |
| Dec 31, 2021 | 1.29M | 904.49K | 232.24% |
| Dec 31, 2020 | 389.47K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |